Oftan Chlora (Chloramphenicol)

Chloramphenicol, the active ingredient in Oftan Chlora, is a broad‑spectrum antibiotic presented as a topical ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in adults and children. GNH USA supplies Oftan Chlora as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chloramphenicol is used for bacterial eye infections, acting on the ocular surface to inhibit microbial growth. - Conjunctivitis: reduces bacterial load and speeds recovery of eye redness and discharge. - Keratitis: controls infection in the cornea, helping preserve visual acuity. - Blepharitis: limits bacterial colonisation of the eyelid margin, decreasing inflammation.

Adverse reactions to chloramphenicol ophthalmic solution are generally mild but can occur.

Common Side Effects: - Burning sensation: mild irritation upon instillation. - Redness: transient conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign‑body sensation: feeling of grit in the eye. - Pruritus: itching of the ocular surface. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Allergic contact dermatitis: swelling, erythema, or rash around the eye. - Stevens‑Johnson syndrome: severe mucocutaneous reaction requiring immediate medical attention. - Toxic optic neuropathy: progressive visual loss with prolonged use. - Bone marrow suppression: rare systemic effect manifesting as anemia or leukopenia. - Pseudomembranous conjunctivitis: formation of a membrane on the conjunctiva. - Corneal ulceration: worsening of corneal integrity in susceptible eyes.

When using chloramphenicol eye drops, consider the following safety measures. - Indication verification: ensure the infection is bacterial and suitable for topical therapy. - Duration of therapy: limit use to the prescribed period to reduce resistance risk. - Pediatric use: exercise caution in newborns and infants; monitor for systemic absorption. - Systemic absorption: be aware of rare systemic toxicity, especially with extensive ocular surface damage. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

Chloramphenicol ophthalmic solution may interact with other ocular medications or systemic agents.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use can increase risk of ototoxicity. - Systemic anticoagulants: may potentiate bleeding tendencies if significant systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Other topical antibiotics: may cause additive irritation or antagonistic effects. - Non‑steroidal anti‑inflammatory eye drops: monitor for increased ocular surface irritation. - Corticosteroid eye drops: assess for delayed wound healing when used together.